Ledger.Open graph →
SEC Form D · filed June 20, 2018

Metacrine, Inc

Offering
$65.0M
Sold
$65.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
San Diego, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Patricia Millican · San Diego, CAExecPatricia Millican · San Diego, CAExecRonald Evans · SAN DIEGO, CADirectorRobert Adelman · South San Francisco, CADirectorAmir Nashat · Cambridge, MADirectorKristina Burow · Ann Arbor, MIDirectorKristina Burow · Chicago, ILDirectorKenneth Song · San Jose, CAExec · DirectorRobert Adelman · DURHAM, NCDirectorCarol Gallagher · San Diego, CADirectorRonald Evans · SAN DIEGO, CADirectorKenneth Song · San Diego, CAExec · DirectorRichard Heyman · San Diego, CADirectorCarol Gallagher · San Diego, CADirectorRichard Heyman · San Diego, CADirectorAmir Nashat · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗